Cargando…

Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes

OBJECTIVE: We examined the association of urine complement proteins with progression to end-stage renal disease (ESRD) or death in people with type 2 diabetes and proteinuric diabetic kidney disease (DKD). RESEARCH DESIGN AND METHODS: Using targeted mass spectrometry, we quantified urinary abundance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaisar, Tomas, Durbin-Johnson, Blythe, Whitlock, Kathryn, Babenko, Ilona, Mehrotra, Rajnish, Rocke, David M., Afkarian, Maryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2018
Materias:	Pathophysiology/Complications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196831/ https://www.ncbi.nlm.nih.gov/pubmed/30150236 http://dx.doi.org/10.2337/dc18-0699

Ejemplares similares

Erratum. Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes. Diabetes Care 2018;41:2361–2369
por: Vaisar, Tomas, et al.
Publicado: (2019)

Urine Leucine-Rich α-2 Glycoprotein 1 (LRG1) Predicts the Risk of Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes
por: Liu, Jian-Jun, et al.
Publicado: (2023)

Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy
por: Bian, Xiaohui, et al.
Publicado: (2019)

Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Bjerre-Christensen, Theis, et al.
Publicado: (2021)

Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes
por: Oshima, Megumi, et al.
Publicado: (2021)

Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes
por: Baker, Nathaniel L., et al.
Publicado: (2018)

Visual impairment and mortality in patients with type 2 diabetes
por: Siersma, Volkert, et al.
Publicado: (2019)

Burden of chronic kidney disease and rapid decline in renal function among adults attending a hospital-based diabetes center in Northern Europe
por: Griffin, Tomás P, et al.
Publicado: (2021)

Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome
por: Undas, Anetta, et al.
Publicado: (2008)

An observational study of patient characteristics and mortality following hypoglycemia in the community
por: Elwen, Francesca R, et al.
Publicado: (2015)

Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study
por: Basu, Madhurima, et al.
Publicado: (2022)

Methylation pattern of urinary DNA as a marker of kidney function decline in diabetes
por: Marumo, Takeshi, et al.
Publicado: (2020)

Two-year longitudinal trajectory patterns of albuminuria and subsequent rates of end-stage kidney disease and all-cause death: a nationwide cohort study of biopsy-proven diabetic kidney disease
por: Yamanouchi, Masayuki, et al.
Publicado: (2021)

Association of the IgG N-glycome with the course of kidney function in type 2 diabetes
por: Singh, Sunny S, et al.
Publicado: (2020)

Urinary adiponectin as a new diagnostic index for chronic kidney disease due to diabetic nephropathy
por: Yamakado, Shinnosuke, et al.
Publicado: (2019)

Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease
por: Mayeda, Laura, et al.
Publicado: (2020)

Klotho prevents epithelial–mesenchymal transition through Egr-1 downregulation in diabetic kidney disease
por: Li, Yang, et al.
Publicado: (2021)

Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
por: Niewczas, Monika A., et al.
Publicado: (2017)

Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS
por: Koshino, Akihiko, et al.
Publicado: (2022)

Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy
por: Okada, Sadanori, et al.
Publicado: (2020)

Early choroidal changes detected by swept-source OCT in type 2 diabetes and their association with diabetic kidney disease
por: Da Silva, Monica Oliveira, et al.
Publicado: (2022)

Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection
por: Vargas-Vázquez, Arsenio, et al.
Publicado: (2021)

Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney disease
por: Nair, Meera, et al.
Publicado: (2020)

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy
por: Skupien, Jan, et al.
Publicado: (2019)

Epidermal Innervation in Type 1 Diabetic Patients: A 2.5-year prospective study after simultaneous pancreas/kidney transplantation
por: Boucek, Petr, et al.
Publicado: (2008)

Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria
por: Krolewski, Andrzej S., et al.
Publicado: (2014)

Glycolytic overload-driven dysfunction of periodontal ligament fibroblasts in high glucose concentration, corrected by glyoxalase 1 inducer
por: Ashour, Amal, et al.
Publicado: (2020)

Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial
por: Lin, Julie, et al.
Publicado: (2008)

Impact of Islet Autoimmunity on the Progressive β-Cell Functional Decline in Type 2 Diabetes
por: Brooks-Worrell, Barbara M., et al.
Publicado: (2014)

Renal histological heterogeneity and functional progress in normoalbuminuric and microalbuminuric Japanese patients with type 2 diabetes
por: Moriya, Tatsumi, et al.
Publicado: (2014)

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial
por: Lachin, John M., et al.
Publicado: (2017)

Progression of Cardiovascular Autonomic Dysfunction in Patients With Type 2 Diabetes: A 7-year follow-up study
por: Ko, Seung-Hyun, et al.
Publicado: (2008)

Spatial Patterns of Structural Brain Changes in Type 2 Diabetic Patients and Their Longitudinal Progression With Intensive Control of Blood Glucose
por: Erus, Guray, et al.
Publicado: (2015)

Shortened Leukocyte Telomere Length Is Associated With Glycemic Progression in Type 2 Diabetes: A Prospective and Mendelian Randomization Analysis
por: Cheng, Feifei, et al.
Publicado: (2022)

En face slab optical coherence tomography imaging successfully monitors progressive degenerative changes in the innermost layer of the diabetic retina
por: Katsuyama, Atsuko, et al.
Publicado: (2020)

Association of HLA-DQ Heterodimer Residues −18β and β57 With Progression From Islet Autoimmunity to Diabetes in the Diabetes Prevention Trial–Type 1
por: Zhao, Lue Ping, et al.
Publicado: (2022)

Clinical and biochemical profile of 786 sequential episodes of diabetic ketoacidosis in adults with type 1 and type 2 diabetes mellitus
por: Ooi, Emma, et al.
Publicado: (2021)

Corneal Confocal Microscopy Identifies Small-Fiber Neuropathy in Subjects With Impaired Glucose Tolerance Who Develop Type 2 Diabetes
por: Azmi, Shazli, et al.
Publicado: (2015)

Natural History of Insulin Sensitivity and Insulin Secretion in the Progression From Normal Glucose Tolerance to Impaired Fasting Glycemia and Impaired Glucose Tolerance: The Inter99 Study
por: Færch, Kristine, et al.
Publicado: (2009)

Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes
por: Kelly, Clare B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sg83lcpheq8f1q00ropjr18gp2